Literature DB >> 1929552

In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis.

M Rupprecht1, R Rupprecht, N Wodarz, H U Braner, J Kornhuber, H U Koch, P Riederer, O P Hornstein.   

Abstract

The effects of glucocorticoids administered in vivo and in vitro on lectin-induced proliferation of lymphocytes sampled from venous blood were investigated in patients with atopic dermatitis (AD) and in normal controls. Stimulation by concanavalin A (Con A), phytohaemagglutinin A (PHA) and pokeweed mitogen (PWM) in patients and controls did not differ significantly under baseline conditions. After in vivo administration of methylprednisolone the decline of Con A-induced blastogenesis of leucocytes was similar in both groups, whereas PHA stimulation caused a significant reduction in the controls only. In vitro addition of different dexamethasone concentrations had a pronounced suppressive effect on Con A- and PHA-induced blastogenesis in both groups, whereas PWM stimulation was unaffected. Pretreatment in vivo with methylprednisolone further decreased the suppression of the Con A and PHA lymphocyte proliferation rate by dexamethasone added in vitro in controls but not in patients. With regard to B-cell proliferation generated by PWM, no consistent glucocorticoid effect could be observed. The impaired effect on lymphocyte blastogenesis of glucocorticoids administered in vivo, in contrast to a normal in vitro reaction to dexamethasone, together with recent findings of an altered glucocorticoid receptor pharmacology in AD, points to a decreased biological in vivo efficiency of methylprednisolone in atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929552     DOI: 10.1007/bf00376616

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  33 in total

1.  Humoral and cellular immunity in atopic eczema.

Authors:  D I Grove; J G Reid; I J Forbes
Journal:  Br J Dermatol       Date:  1975-06       Impact factor: 9.302

2.  Nonspecific suppressor cell function in atopic subjects.

Authors:  J D Martinez; J Santos; D J Stechschulte; N I Abdou
Journal:  J Allergy Clin Immunol       Date:  1979-12       Impact factor: 10.793

3.  Elevated glucocorticoid receptor concentrations before and after glucocorticoid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis.

Authors:  M Rupprecht; R Rupprecht; J Kornhuber; N Wodarz; H U Koch; P Riederer; O P Hornstein
Journal:  Dermatologica       Date:  1991

4.  Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria.

Authors:  L Juhlin; G O Johansson; H Bennich; C Högman; N Thyresson
Journal:  Arch Dermatol       Date:  1969-07

5.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Psychophysiological analysis of atopic dermatitis.

Authors:  M E Faulstich; D A Williamson; E G Duchmann; S L Conerly; P J Brantley
Journal:  J Psychosom Res       Date:  1985       Impact factor: 3.006

7.  Plasma aldosterone and cortisol levels in psoriasis and atopic dermatitis.

Authors:  P C van de Kerkhof
Journal:  Br J Dermatol       Date:  1982-04       Impact factor: 9.302

8.  Abnormal suppressor cell function in atopic dermatitis.

Authors:  M Rola-Pleszczynski; R Blanchard
Journal:  J Invest Dermatol       Date:  1981-04       Impact factor: 8.551

9.  Enumeration of T cell subsets in atopic dermatitis using monoclonal antibodies.

Authors:  D Y Leung; A R Rhodes; R S Geha
Journal:  J Allergy Clin Immunol       Date:  1981-06       Impact factor: 10.793

10.  Alternate-day prednisone therapy and human lymphocyte subpopulations.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

View more
  2 in total

Review 1.  Lectins Are the Sparkle of Hope for Combating Coronaviruses and the Global COVID-19.

Authors:  Heba Salah Abbas; Muddukrishnaiah Kotakonda
Journal:  Adv Pharm Bull       Date:  2021-03-27

2.  Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.